Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Akkaraju Srinivas
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   3,961,226    

Indirect Shares

  37,470,445      
Direct Value   $19,702,089    

Indirect Value

  $276,102,231      
Total Shares   41,431,671      
Total Value   $295,804,320      


Seagen Inc
 $9,493,396 Paratek Pharmaceuticals Inc
 $2,635,786 Icagen Inc
 $0 MEI Pharma Inc
 $7,558,381 Aravive Inc
 $1,276 Syros Pharmaceuticals, Inc.
 $13,250 Seagen Inc
 $9,493,396 Paratek Pharmaceuticals Inc
 $2,635,786 Icagen Inc
 $0 MEI Pharma Inc
 $7,558,381 Aravive Inc
 $1,276 Syros Pharmaceuticals, Inc.
 $13,250
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    5   
    3    

     Stock price went up :

    4   
    1    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   4.0   
   4.0   
     Percentage Gain/Loss :
   28.4%
 -84.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmos Corp PARS Director 0 2006-10-25 2,845,160    Premium*  
            Seagen Inc SGEN Director 2020-05-15 41,503 2008-09-22 600,559    Premium*  
            Paratek Pharmaceuticals Inc PRTK Former 10% Beneficial ... 2011-07-19 1,181,967 0    Premium*  
            World Heart Corp WHRT 10% Owner 2012-08-02 0 2010-01-26 0    Premium*  
            Icagen Inc ICGN 2011-07-28 200,500 0    Premium*  
            Synageva BioPharma Corp GEVA Former Director 0 2012-06-27 1,026,832    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2012-07-24 0 2012-07-24 3,028,439    Premium*  
            MEI Pharma Inc MEIP 10% Owner 2013-02-19 2,502,775 0    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 609,455    Premium*  
            aTyr Pharma Inc LIFE Former 10% Owner, Dire... 2015-05-12 0 2015-05-12 1,866,126    Premium*  
            Aravive Inc ARAV Director 2019-12-02 31,815 2019-12-02 576,066    Premium*  
            Syros Pharmaceuticals, Inc. SYRS Director 2023-12-21 2,666 2023-12-21 1,786,427    Premium*  
            Principia Biopharma Inc PRNB Director 2018-09-18 0 2018-09-18 383,480    Premium*  
            Chinook Therapeutics Inc KDNY Director 2023-08-11 0 2023-08-11 0    Premium*  
            Lenz Therapeutics LENZ 10% Owner 2021-06-29 0 2022-04-12 8,497,067    Premium*  
            Scholar Rock Holding Corp SRRK Director, 10% Owner 0 2023-10-16 6,788,609    Premium*  
            Cargo Therapeutics, Inc. CRGX 10% Owner 0 2023-11-14 4,121,689    Premium*  
            Mineralys Therapeutics, Inc. MLYS 2024-02-12 0 2024-02-12 5,074,916    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-02-27 0 2024-02-27 265,620    Premium*  
* Premium Members only  

Records found :    123         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2023-12-21 4 B $4.42 $3,999,998 I/I 904,977 1,786,427 2.1 %
PRTK Paratek Pharmaceuticals I... Former 10% Beneficial Owner   –       –      –    2011-07-19 4 S $4.45 $367,198 D/D (82,535) 1,181,967 0 -
PRTK Paratek Pharmaceuticals I... Former 10% Beneficial Owner   –       –      –    2011-07-18 4 S $4.49 $729,259 D/D (162,527) 1,264,502 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2011-07-14 4 S $4.85 $202,245 D/D (41,718) 1,427,029 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2011-07-13 4 S $5.02 $843,833 D/D (168,235) 1,468,747 0 -
WHRT World Heart Corp 10% Owner   –       –       •   2010-01-26 4 B $5.15 $2,000,003 D/D 388,350 3,721,683 2.45 -
MEIP MEI Pharma Inc 10% Owner   –       –       •   2013-02-15 4 S $6.60 $1,301,685 D/D (197,225) 2,802,775 0 -
MEIP MEI Pharma Inc 10% Owner   –       –       •   2013-02-19 4 S $6.80 $2,040,000 D/D (300,000) 2,502,775 0 -
SRRK Scholar Rock Holding Corp Director   –       •       •   2023-10-16 4 B $6.85 $15,000,000 I/I 2,189,781 6,788,609 2.25 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2019-04-09 4 B $7.50 $3,999,990 I/I 533,332 1,593,270 2.1 -
ARAV Aravive Inc Director   –       •      –    2019-12-02 4 B $7.50 $999,998 I/I 133,333 576,066 2.1 -
SGEN Seagen Inc Director   –       •      –    2013-06-14 4 OE $8.38 $41,900 D/D 5,000 18,905 0 -
SGEN Seagen Inc Director   –       •      –    2018-10-30 4 OE $8.38 $41,900 D/D 5,000 37,205 0 -
SGEN Seagen Inc Director   –       •      –    2007-02-09 4 S $8.57 $17,268,550 I/I (2,015,000) 0 0 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-24 4 B $8.70 $200,100 I/I 23,000 8,034,850 1.5 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-20 4 B $8.92 $384,497 I/I 43,105 7,911,850 1.5 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2017-12-13 4 B $8.97 $613,548 I/I 68,400 803,894 2.1 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2017-12-14 4 B $8.99 $239,134 I/I 26,600 830,494 2.1 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-21 4 B $8.99 $899,000 I/I 100,000 8,011,850 1.5 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 B $9.00 $7,058,817 I/I 784,313 3,028,439 1.5 -
SGEN Seagen Inc Director   –       •      –    2009-06-25 4 B $9.20 $50,633 D/D 5,500 5,500 2.39 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-19 4 B $9.24 $504,181 I/I 54,565 7,868,745 1.5 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2017-12-12 4 B $9.40 $138,876 I/I 14,774 735,494 2.1 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2018-01-31 4 B $9.55 $1,999,999 I/I 209,424 1,059,938 2.1 -
SGEN Seagen Inc Director   –       •      –    2008-05-13 4 S $10.06 $512,014 I/I (50,896) 1,005,407 0 -

  123  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed